NW CORPORATE RESULTS | Dollar figures in thousands, except per share; parentheses denote losses. Pyramid Breweries Beer Dec. 31 % 4th QTR...

Share story

Dollar figures in thousands, except per share; parentheses denote losses.

Pyramid Breweries
Beer
Dec. 31 %
4th QTR 2007 2006 CHG
Profit ($1,813) ($1,214) -49.3
Per share (0.20) (0.14) -42.9
Net sales 11,505 11,658 -1.3
ANNUAL 2007 2006 CHG
Profit ($488) ($1,561) +68.7
Per share (0.05) (0.18) +72.2
Net sales 48,251 50,356 -4.2
COMMENT: Seattle-based Pyramid sold Thomas Kemper Soda last year to focus on beer. Although it still manufactures pop for the new owner, its pop sales and margins are lower than they used to be. Alehouse revenue rose 5 percent in the fourth quarter. Beer shipments were up 7 percent.
Sonus Pharmaceuticals
Biotechnology
Dec. 31 %
4th QTR 2007 2006 CHG
Profit $1,933 ($7,013)
Per share 0.05 (0.19)
Sales 7,730 5,893 +31.2
ANNUAL 2007 2006 CHG
Profit ($13,063) ($23,551) +44.5
Per share (0.35) (0.68) +48.5
Sales 20,131 22,392 -10.1
COMMENT: Sonus’ loss narrowed as the company slowed down clinical development after the failure of a recent clinical trial. CEO Michael Martino said the Bothell company, which has $34 million in cash, was considering acquiring or licensing clinical-stage products or merging with other companies.